NCT00426595View on ClinicalTrials.gov

Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Gastreoesophageal Reflux Disease
Interventions
DRUG

Administration of omeprazole suspension

DRUG

omeprazole administered as a multi-unit-pellet system

Trial Locations (1)

9000

University Hospital Ghent, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT00426595 - Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation | Biotech Hunter | Biotech Hunter